Eisai Co Ltd
TSE:4523
Intrinsic Value
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. [ Read More ]
The intrinsic value of one Eisai Co Ltd stock under the Base Case scenario is 7 616.6 JPY. Compared to the current market price of 5 901 JPY, Eisai Co Ltd is Undervalued by 23%.
Valuation Backtest
Eisai Co Ltd
Run backtest to discover the historical profit from buying and selling Eisai Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Eisai Co Ltd
Current Assets | 661B |
Cash & Short-Term Investments | 285.2B |
Receivables | 186.2B |
Other Current Assets | 189.6B |
Non-Current Assets | 650.2B |
Long-Term Investments | 58.6B |
PP&E | 159.9B |
Intangibles | 307.8B |
Other Non-Current Assets | 123.9B |
Current Liabilities | 277.8B |
Accounts Payable | 56.1B |
Other Current Liabilities | 221.7B |
Non-Current Liabilities | 214.6B |
Long-Term Debt | 134.8B |
Other Non-Current Liabilities | 79.8B |
Earnings Waterfall
Eisai Co Ltd
Revenue
|
749.5B
JPY
|
Cost of Revenue
|
-157.8B
JPY
|
Gross Profit
|
591.7B
JPY
|
Operating Expenses
|
-525.7B
JPY
|
Operating Income
|
65.9B
JPY
|
Other Expenses
|
-20.5B
JPY
|
Net Income
|
45.4B
JPY
|
Free Cash Flow Analysis
Eisai Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Eisai Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Eisai Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Eisai Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Eisai Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Eisai Co Ltd
According to Wall Street analysts, the average 1-year price target for Eisai Co Ltd is 8 083.42 JPY with a low forecast of 5 656 JPY and a high forecast of 11 130 JPY.
Shareholder Return
Price
Eisai Co Ltd
Average Annual Return | 9.87% |
Standard Deviation of Annual Returns | 19.75% |
Max Drawdown | -59% |
Market Capitalization | 1.7T JPY |
Shares Outstanding | 286 806 000 |
Percentage of Shares Shorted |
N/A
|
News
Last Important Events
Eisai Co Ltd
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Eisai Co Ltd
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. The company is headquartered in Bunkyo-Ku, Tokyo-To and currently employs 11,237 full-time employees. The firm operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The firm is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Contact
IPO
Employees
Officers
The intrinsic value of one Eisai Co Ltd stock under the Base Case scenario is 7 616.6 JPY.
Compared to the current market price of 5 901 JPY, Eisai Co Ltd is Undervalued by 23%.